John Kelsall

Featured in: Favicon

Articles

Real-World Incidence and Determinants of Infection in Patients With Rheumatoid Arthritis Treated With Golimumab After a Median Follow-Up Time of 27 Months

Sep 1, 2023 | jrheum.org | Louis Bessette |Proton Rahman |John Kelsall |Jane Purvis

Real-World Incidence and Determinants of Infection in Patients With Rheumatoid Arthritis Treated With Golimumab After a Median Follow-Up Time of 27 Months Louis Bessette, Proton Rahman, John Kelsall, Jane Purvis, Emmanouil Rampakakis, Allen J. Lehman, Meagan Rachich, Francois Nantel, Odalis Asin-Milan, A. Marilise Marrache The Journal of Rheumatology Sep 2023, 50 (9) 1121-1126; DOI: 10.3899/jrheum.2022-1283

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.